NO20055758D0 - Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonister - Google Patents
Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonisterInfo
- Publication number
- NO20055758D0 NO20055758D0 NO20055758A NO20055758A NO20055758D0 NO 20055758 D0 NO20055758 D0 NO 20055758D0 NO 20055758 A NO20055758 A NO 20055758A NO 20055758 A NO20055758 A NO 20055758A NO 20055758 D0 NO20055758 D0 NO 20055758D0
- Authority
- NO
- Norway
- Prior art keywords
- heteroaryl
- receptor antagonists
- glutamate receptor
- imidazole derivatives
- substituted imidazole
- Prior art date
Links
- 239000003825 glutamate receptor antagonist Substances 0.000 title 1
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03012290 | 2003-06-12 | ||
PCT/EP2004/006111 WO2004111040A1 (en) | 2003-06-12 | 2004-06-07 | Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20055758D0 true NO20055758D0 (no) | 2005-12-05 |
NO20055758L NO20055758L (no) | 2005-12-07 |
NO332175B1 NO332175B1 (no) | 2012-07-16 |
Family
ID=33495606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055758A NO332175B1 (no) | 2003-06-12 | 2005-12-05 | Heteroarylsubstituerte imidazolderivater, fremstilling av slike forbindelser, medikament inneholdende slike forbindelser, slike forbindelser for anvendelse til behandling av sykdom samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom |
Country Status (24)
Country | Link |
---|---|
US (1) | US7241760B2 (no) |
EP (1) | EP1670784B1 (no) |
JP (1) | JP4395512B2 (no) |
KR (1) | KR100717914B1 (no) |
CN (1) | CN100462363C (no) |
AR (1) | AR044657A1 (no) |
AT (1) | ATE495168T1 (no) |
AU (1) | AU2004247368B2 (no) |
BR (1) | BRPI0411350A (no) |
CA (1) | CA2527587C (no) |
CL (1) | CL2004001430A1 (no) |
CO (1) | CO5660263A2 (no) |
DE (1) | DE602004031030D1 (no) |
ES (1) | ES2358512T3 (no) |
HK (1) | HK1093071A1 (no) |
IL (1) | IL172080A (no) |
MX (1) | MXPA05013233A (no) |
MY (1) | MY140206A (no) |
NO (1) | NO332175B1 (no) |
NZ (1) | NZ543638A (no) |
RU (1) | RU2327697C2 (no) |
TW (1) | TWI336700B (no) |
WO (1) | WO2004111040A1 (no) |
ZA (1) | ZA200509908B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452909B2 (en) * | 2003-09-04 | 2008-11-18 | Hoffman-La Roche Inc. | Imidazole derivatives |
KR100968989B1 (ko) | 2005-03-23 | 2010-07-09 | 에프. 호프만-라 로슈 아게 | mGluR2 길항제로서 아세틸렌일-피라졸로-피리미딘 유도체 |
CN101273040B (zh) | 2005-09-27 | 2011-11-09 | 弗·哈夫曼-拉罗切有限公司 | 作为mglur2拮抗剂的*二唑基吡唑并嘧啶类化合物 |
DE102006011574A1 (de) | 2006-03-10 | 2007-10-31 | Grünenthal GmbH | Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln |
WO2009024491A1 (en) * | 2007-08-20 | 2009-02-26 | F. Hoffmann-La Roche Ag | Use of mglur5 antagonists for the treatment of gerd |
US8334287B2 (en) * | 2009-07-17 | 2012-12-18 | Hoffmann-La Roche Inc. | Imidazoles |
US9447099B2 (en) | 2011-10-04 | 2016-09-20 | Hoffmann-La Roche Inc. | Methods for the preparation of 5-[2-[7 (trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo [1,5-A]pyrimidin-3-yl[ethynyl]-2-pyridinamine |
WO2021110574A1 (en) * | 2019-12-02 | 2021-06-10 | F. Hoffmann-La Roche Ag | Alkynyl-(heteroaryl)-carboxamide hcn1 inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354867A (en) * | 1988-12-06 | 1994-10-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
EP1214303A1 (en) * | 1999-08-31 | 2002-06-19 | Merck & Co., Inc. | Heterocyclic compounds and methods of use thereof |
US6774138B2 (en) * | 1999-08-31 | 2004-08-10 | Merck & Co., Inc. | Thiazolyl(pyridyl)ethyne compounds |
CA2416442C (en) * | 2000-07-24 | 2010-06-08 | Krenitsky Pharmaceuticals, Inc. | Substituted 5-alkynyl pyrimidines having neurotrophic activity |
DE10040683C2 (de) * | 2000-08-19 | 2002-06-27 | Hinderer & Muehlich Kg | Verfahren zum Positionieren einer Patrize an einer Gegendruckwalze einer Prägestation |
WO2002046166A1 (en) * | 2000-12-04 | 2002-06-13 | F. Hoffmann-La Roche Ag | Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
-
2004
- 2004-06-07 WO PCT/EP2004/006111 patent/WO2004111040A1/en active IP Right Grant
- 2004-06-07 RU RU2006100106/04A patent/RU2327697C2/ru not_active IP Right Cessation
- 2004-06-07 CA CA2527587A patent/CA2527587C/en not_active Expired - Fee Related
- 2004-06-07 JP JP2006515286A patent/JP4395512B2/ja not_active Expired - Fee Related
- 2004-06-07 AT AT04739649T patent/ATE495168T1/de active
- 2004-06-07 BR BRPI0411350-0A patent/BRPI0411350A/pt not_active IP Right Cessation
- 2004-06-07 EP EP04739649A patent/EP1670784B1/en not_active Not-in-force
- 2004-06-07 ES ES04739649T patent/ES2358512T3/es active Active
- 2004-06-07 MX MXPA05013233A patent/MXPA05013233A/es active IP Right Grant
- 2004-06-07 NZ NZ543638A patent/NZ543638A/en not_active IP Right Cessation
- 2004-06-07 AU AU2004247368A patent/AU2004247368B2/en not_active Ceased
- 2004-06-07 KR KR1020057023885A patent/KR100717914B1/ko not_active IP Right Cessation
- 2004-06-07 CN CNB2004800158698A patent/CN100462363C/zh not_active Expired - Fee Related
- 2004-06-07 DE DE602004031030T patent/DE602004031030D1/de active Active
- 2004-06-09 TW TW093116555A patent/TWI336700B/zh not_active IP Right Cessation
- 2004-06-09 CL CL200401430A patent/CL2004001430A1/es unknown
- 2004-06-10 MY MYPI20042241A patent/MY140206A/en unknown
- 2004-06-10 AR ARP040102004A patent/AR044657A1/es active IP Right Grant
- 2004-06-12 US US10/866,255 patent/US7241760B2/en not_active Expired - Fee Related
-
2005
- 2005-11-21 IL IL172080A patent/IL172080A/en not_active IP Right Cessation
- 2005-12-05 CO CO05123374A patent/CO5660263A2/es active IP Right Grant
- 2005-12-05 NO NO20055758A patent/NO332175B1/no not_active IP Right Cessation
- 2005-12-06 ZA ZA200509908A patent/ZA200509908B/xx unknown
-
2006
- 2006-12-18 HK HK06113875.7A patent/HK1093071A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2017032I1 (el) | Παραγωγα (θειο)καρβαμοϋλ-κυκλοεξανιου ως ανταγωνιστες των υποδοχεων d3/d2 | |
DK1761519T3 (da) | Indolderivater som histaminreceptorantagonister | |
DK1539742T3 (da) | Indolderivater, der er nyttige som histamin H3-antagonister | |
DK1833791T3 (da) | 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister | |
DK1499316T3 (da) | (1-4-piperidinyl)benzimidazolderivater anvendelige som histamin-H3-antagonister | |
IL171930A0 (en) | Imidazole derivatives as glutamate receptor antagonists | |
NO20052797D0 (no) | Fenyl eller heteroaryl aminoalkanderivater som IP-reseptorantagonister | |
ATE384053T1 (de) | Triazolderivate als tachykininrezeptor- antagonisten | |
IS7667A (is) | Nýjar bensimídazólafleiður | |
NO20054951D0 (no) | Prostaglandinanaloger som EP4-reseptorantagonister | |
DK1745009T3 (da) | Heteroarylsubstituerede cyklohexyl-1,4-diamin-derivater | |
DK1904477T3 (da) | Indol-3-carbonyl-spiro-piperodom-derivater som V1A-receptorantagonister | |
ATE517888T1 (de) | Indolylmaleimid-derivate | |
DK1802307T3 (da) | Pyrrolidinderivater som histamin-receptor-ligander | |
DK1668014T3 (da) | Kondenserede heterocykliske forbindelser som serotoninreceptormodulatorer | |
DK1740569T3 (da) | Imidazol-derivater som TAFla-inhibitorer | |
ATE386518T1 (de) | Benzimidazolderivate | |
NO20055758D0 (no) | Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonister | |
DK1928821T3 (da) | Carboxamidderivater som muscarinreceptorantagonister | |
DK1912976T3 (da) | Indol-3-YL-carbonyl-piperidin-benzoimidazolderivater som V1A-receptorantagonister | |
NO20044373L (no) | Azetidinderivater som CCR-3-reseptorantagonister | |
DE60316411D1 (de) | Thiazolderivate als npy-rezeptorantagonisten | |
DK1560828T3 (da) | Imidazoquinolinderivater som adenosin-A3-receptorligander | |
ATE427945T1 (de) | Imidazolderivate | |
NO20055725D0 (no) | Glutamatreseptorantagonister som neurobeskyttende midler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |